Media & Resources

NEW YORK, August 19, 2009─Dianne Stewart, former head of Board and Donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, has joined the International AIDS Vaccine Initiative (IAVI) as Vice President of Resource Development.  In her role at IAVI, Ms. Stewart will provide leadership for the organization’s fundraising strategy focused on both…

 August 6, 2009. For the eighth consecutive year, the International AIDS Vaccine Initiative (IAVI) has received a four-star rating from Charity Navigator, America’s largest independent evaluator of charities. This rating indicates that IAVI, a nonprofit organization dedicated solely to AIDS vaccine development, excels in managing its finances efficiently and effectively. That is to say, nearly…

Shifting scientific, health priorities and global economic downturn impact investment in HIV prevention R&D Cape Town – A new report on investment in HIV prevention research in 2008 finds that HIV vaccine research funding levels decreased for the first time since investment trends have been tracked. This may have been influenced by shifts in scientific…

SEATTLE & NEW YORK–(BUSINESS WIRE)–Theraclone Sciences, Inc. and the International AIDS Vaccine Initiative (IAVI) have announced an expansion of their HIV antibody discovery program. In 2008, Theraclone was granted an award under IAVI’s Innovation Fund to test its unique process for isolating, from the blood of certain HIV-infected individuals, potent monoclonal antibodies to HIV that…

A statement from Dr. Seth Berkley of the International AIDS Vaccine Initiative NEW YORK, NY – May 15, 2009 – World AIDS Vaccine Day, May 18, marks the occasion in 1997 when U.S. President Bill Clinton challenged researchers to come up with an AIDS vaccine within the following decade, stating that such a vaccine was…

NEW YORK, May 5, 2009─Dr. C. Richter (Rick) King, former Senior Vice President of Research at GenVec, Inc., has joined the International AIDS Vaccine Initiative (IAVI) as Vice President of Vaccine Discovery.  In his new position, Dr. King will play a vital role in leading and managing IAVI’s global vaccine discovery initiatives in support of…

NEW YORK, NY, April 30, 2009 — TIME magazine has named Dr. Seth Berkley, President and CEO of the International AIDS Vaccine Initiative (IAVI), one of this year’s “100 Most Influential People in the World.” Berkley, a medical doctor and infectious disease epidemiologist, is joined by world leaders, icons, thinkers, visionaries and others whose ideas…

This World AIDS Day comes at a time of remarkable progress in biomedical HIV prevention. In late November, researchers announced that in a Phase III trial, a daily dose of an antiretroviral (ARV) treatment taken as prophylaxis reduced HIV infection in men at high risk by 44%. Earlier, a vaginal microbicide gel reduced HIV infection…